Holista CollTech Ltd
ASX:HCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Holista CollTech Ltd
Cash & Cash Equivalents
Holista CollTech Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Holista CollTech Ltd
ASX:HCT
|
Cash & Cash Equivalents
AU$2.2m
|
CAGR 3-Years
164%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
41%
|
|
|
Bioxyne Ltd
ASX:BXN
|
Cash & Cash Equivalents
AU$7.6m
|
CAGR 3-Years
26%
|
CAGR 5-Years
34%
|
CAGR 10-Years
20%
|
|
|
S
|
Skin Elements Ltd
ASX:SKN
|
Cash & Cash Equivalents
AU$1.7m
|
CAGR 3-Years
54%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
McPherson's Ltd
ASX:MCP
|
Cash & Cash Equivalents
AU$12.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Cash & Cash Equivalents
AU$4.1m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Cash & Cash Equivalents
AU$2.7m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
Holista CollTech Ltd
Glance View
Holista CollTech Ltd. engages in the research, development, manufacture, and marketing of natural ingredients and wellness products. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2004-02-26. The firm is focused on researching, developing, manufacturing, and marketing health-style products. The firm's segments include Supplements, Ovine collagen, Food ingredients, and Infection control. The Supplements segment is engaged in the manufacture and wholesale distribution of dietary supplements. Ovine collagen is engaged in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is engaged in the manufacture and wholesale distribution of healthy food ingredients. Infection control segment is engaged in the infection control solutions. Its Path-Away technology is developed from bioflavonoids, which kill approximately 170 viruses, bacteria and fungi-naturally and without side effects. The firm's products include M3 System, FogClean, OVICOLL 98, OVICOLL 95, OVINEX and GILite.
See Also
What is Holista CollTech Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.2m
AUD
Based on the financial report for Dec 31, 2025, Holista CollTech Ltd's Cash & Cash Equivalents amounts to 2.2m AUD.
What is Holista CollTech Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
41%
Over the last year, the Cash & Cash Equivalents growth was 9 858%. The average annual Cash & Cash Equivalents growth rates for Holista CollTech Ltd have been 164% over the past three years , -5% over the past five years , and 41% over the past ten years .
